Elanco Animal Health Incorporated
ELAN
$21.43
-$0.29-1.34%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.89B | 4.72B | 4.59B | 4.48B | 4.43B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.89B | 4.72B | 4.59B | 4.48B | 4.43B |
| Cost of Revenue | 2.20B | 2.12B | 2.07B | 2.03B | 2.00B |
| Gross Profit | 2.69B | 2.59B | 2.52B | 2.45B | 2.43B |
| SG&A Expenses | 1.46B | 1.42B | 1.39B | 1.36B | 1.31B |
| Depreciation & Amortization | 553.00M | 543.00M | 534.00M | 527.00M | 522.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.59B | 4.46B | 4.34B | 4.27B | 4.18B |
| Operating Income | 307.00M | 259.00M | 247.00M | 215.00M | 245.00M |
| Income Before Tax | -197.00M | -224.00M | -16.00M | 593.00M | 536.00M |
| Income Tax Expenses | 45.00M | 8.00M | -52.00M | 159.00M | 163.00M |
| Earnings from Continuing Operations | -242.00 | -232.00 | 36.00 | 434.00 | 373.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -242.00M | -232.00M | 36.00M | 434.00M | 373.00M |
| EBIT | 307.00M | 259.00M | 247.00M | 215.00M | 245.00M |
| EBITDA | 970.00M | 908.00M | 882.00M | 842.00M | 863.00M |
| EPS Basic | -0.49 | -0.47 | 0.07 | 0.88 | 0.75 |
| Normalized Basic EPS | 0.08 | 0.04 | 0.04 | -0.01 | 0.02 |
| EPS Diluted | -0.50 | -0.48 | 0.06 | 0.86 | 0.74 |
| Normalized Diluted EPS | 0.08 | 0.04 | 0.04 | -0.01 | 0.02 |
| Average Basic Shares Outstanding | 1.99B | 1.99B | 1.98B | 1.98B | 1.98B |
| Average Diluted Shares Outstanding | 2.00B | 1.99B | 1.99B | 1.99B | 1.99B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |